USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	064286/0472			Pages:	66
		Recorded:	07/17/2023
Attorney Dkt #:	2066405 PAT
Conveyance:	RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).

Total properties: 26

Patent #:	7803931	Issue Dt:	09/28/2010	Application #:	11058134	Filing Dt:	02/14/2005
Publication #:	US20060018871	Pub Dt:	01/26/2006
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	7538211	Issue Dt:	05/26/2009	Application #:	11318227	Filing Dt:	12/22/2005
Publication #:	US20060105980	Pub Dt:	05/18/2006
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	7579456	Issue Dt:	08/25/2009	Application #:	11354657	Filing Dt:	02/14/2006
Publication #:	US20070048248	Pub Dt:	03/01/2007
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	8236773	Issue Dt:	08/07/2012	Application #:	11884411	Filing Dt:	08/26/2008
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	8436164	Issue Dt:	05/07/2013	Application #:	13525680	Filing Dt:	06/18/2012
Publication #:	US20120322860	Pub Dt:	12/20/2012
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	9617546	Issue Dt:	04/11/2017	Application #:	14573423	Filing Dt:	12/17/2014
Publication #:	US20150159158	Pub Dt:	06/11/2015
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	11118185	Issue Dt:	09/14/2021	Application #:	16081307	Filing Dt:	08/30/2018
Publication #:	US20190093111	Pub Dt:	03/28/2019
Title:	AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA

Patent #:	10947544	Issue Dt:	03/16/2021	Application #:	16289374	Filing Dt:	02/28/2019
Publication #:	US20190185858	Pub Dt:	06/20/2019
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	10526315	Issue Dt:	01/07/2020	Application #:	16312211	Filing Dt:	12/20/2018
Publication #:	US20190202810	Pub Dt:	07/04/2019
Title:	CARBOCYCLIC PROLINAMIDE DERIVATIVES

Patent #:	11377439	Issue Dt:	07/05/2022	Application #:	16312247	Filing Dt:	12/20/2018
Publication #:	US20190322645	Pub Dt:	10/24/2019
Title:	HETEROCYCLIC PROLINAMIDE DERIVATIVES

Patent #:	10730832	Issue Dt:	08/04/2020	Application #:	16312259	Filing Dt:	12/20/2018
Publication #:	US20190330146	Pub Dt:	10/31/2019
Title:	ALIPHATIC PROLINAMIDE DERIVATIVES

Patent #:	11739346	Issue Dt:	08/29/2023	Application #:	16500238	Filing Dt:	10/02/2019
Publication #:	US20200056204	Pub Dt:	02/20/2020
Title:	MINIGENE THERAPY

Patent #:	11267803	Issue Dt:	03/08/2022	Application #:	16734740	Filing Dt:	01/06/2020
Publication #:	US20200385362	Pub Dt:	12/10/2020
Title:	CARBOCYCLIC PROLINAMIDE DERIVATIVES

Patent #:	11596667	Issue Dt:	03/07/2023	Application #:	16764718	Filing Dt:	05/15/2020
Publication #:	US20210169975	Pub Dt:	06/10/2021
Title:	A METHOD FOR TREATING OR PREVENTING IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)

Patent #:	NONE	Issue Dt:		Application #:	17059815	Filing Dt:	11/30/2020
Publication #:	US20210207147	Pub Dt:	07/08/2021
Title:	COMPOSITIONS AND METHODS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA

Patent #:	11913000	Issue Dt:	02/27/2024	Application #:	17200536	Filing Dt:	03/12/2021
Publication #:	US20210332361	Pub Dt:	10/28/2021
Title:	APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	17272203	Filing Dt:	02/26/2021
Publication #:	US20220033826	Pub Dt:	02/03/2022
Title:	ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE

Patent #:	NONE	Issue Dt:		Application #:	17327609	Filing Dt:	05/21/2021
Publication #:	US20210324387	Pub Dt:	10/21/2021
Title:	AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA

Patent #:	11273171	Issue Dt:	03/15/2022	Application #:	17346556	Filing Dt:	06/14/2021
Publication #:	US20210369757	Pub Dt:	12/02/2021
Title:	METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

Patent #:	11866422	Issue Dt:	01/09/2024	Application #:	17375973	Filing Dt:	07/14/2021
Publication #:	US20210347762	Pub Dt:	11/11/2021
Title:	CARBOCYCLIC PROLINAMIDE DERIVATIVES

Patent #:	NONE	Issue Dt:		Application #:	17604545	Filing Dt:	10/18/2021
Publication #:	US20220202959	Pub Dt:	06/30/2022
Title:	GENE THERAPIES FOR USHER SYNDROME (USH2A)

Patent #:	NONE	Issue Dt:		Application #:	17604556	Filing Dt:	10/18/2021
Publication #:	US20220177539	Pub Dt:	06/09/2022
Title:	GENE THERAPIES FOR STARGARDT DISEASE (ABCA4)

Patent #:	NONE	Issue Dt:		Application #:	17612653	Filing Dt:	11/19/2021
Publication #:	US20220233720	Pub Dt:	07/28/2022
Title:	MINIGENE THERAPY

Patent #:	11491176	Issue Dt:	11/08/2022	Application #:	17676811	Filing Dt:	02/21/2022
Publication #:	US20220175813	Pub Dt:	06/09/2022
Title:	METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

Patent #:	NONE	Issue Dt:		Application #:	17738872	Filing Dt:	05/06/2022
Publication #:	US20220267306	Pub Dt:	08/25/2022
Title:	HETEROCYCLIC PROLINAMIDE DERIVATIVES

Patent #:	NONE	Issue Dt:		Application #:	17772291	Filing Dt:	04/27/2022
Publication #:	US20220370629	Pub Dt:	11/24/2022
Title:	ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD

Assignor

HERCULES CAPITAL, INC.

Exec Dt:

07/11/2023

Assignees

IVERIC BIO, INC.

8 SYLVAN WAY

PARSIPPANY, NEW JERSEY 07054

IVERIC BIO GENE THERAPY LLC

8 SYLVAN WAY

PARSIPPANY, NEW JERSEY 07054

ORION OPHTHALMOLOGY LLC

8 SYLVAN WAY

PARSIPPANY, NEW JERSEY 07054

Correspondence name and address
	JAY DASILVA
	1025 CONNECTICUT AVE., NW, STE. 712
	COGENCY GLOBAL INC.
	WASHINGTON, DC 20036

Search Results as of: 05/30/2024 05:32 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6